KALYANA SWAMINATHAN ASHOK
Known title: Sr VP & Gen Mgr, Life SciencesCIK: 0001801437
Associated companies
Transaction History
| ASH | ▲ Buy | Option Exercise | 869 | $68K | 11/18/2023 | View on chart |
| ASH | ▼ Sell | Tax Withholding | 298 | $23K | 11/18/2023 | View on chart |
| ASH | ▲ Buy | Option Exercise | 589 | $45K | 11/17/2023 | View on chart |
| ASH | ▼ Sell | Tax Withholding | 202 | $16K | 11/17/2023 | View on chart |
| ASH | ▲ Buy | Option Exercise | 798 | $61K | 11/17/2023 | View on chart |
| ASH | ▼ Sell | Tax Withholding | 274 | $21K | 11/17/2023 | View on chart |
| ASH | ▼ Sell | Tax Withholding | 294 | $23K | 11/17/2023 | View on chart |
| ASH | ▲ Buy | Grant | 858 | $66K | 11/17/2023 | View on chart |
| ASH | ▲ Buy | Grant | 2,030 | $175K | 8/18/2023 | View on chart |
| ASH | ▼ Sell | Tax Withholding | 637 | $55K | 8/18/2023 | View on chart |
| ASH | ▲ Buy | Option Exercise | 275 | $25K | 8/3/2023 | View on chart |
| ASH | ▲ Buy | Option Exercise | 853 | $95K | 11/18/2022 | View on chart |
| ASH | ▲ Buy | Option Exercise | 580 | $64K | 11/17/2022 | View on chart |
| ASH | ▲ Buy | Option Exercise | 270 | $27K | 8/3/2022 | View on chart |
| ASH | ▼ Sell | Tax Withholding | 85 | $9K | 8/3/2022 | View on chart |
| ASH | ▲ Buy | Option Exercise | 571 | $61K | 11/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
ASH: UBS lowers price target to $80
UBS kept its rating unchanged on Ashland Inc. and reduced its price target to $80. The new target is close to the average analyst consensus of $80.18 and sits near the top of the stock’s 52‑week range. With a trailing P/E of 62 and a dividend yield of 1.94%, the adjustment reflects expectations for future earnings growth.
ASH: UBS lowers price target to $80. UBS kept its rating unchanged on Ashland Inc. and reduced its price target to $80. The new target is close to the average analyst consensus of $80.18 and sits near the top of the stock’s 52‑week range. With a trailing P/E of 62 and a dividend yield of 1.94%, the adjustment reflects expectations for future earnings growth.